Wells Fargo & Company Vir Biotechnology, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 42,416 shares of VIR stock, worth $313,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,416

Previous 29,796 42.35%

Holding current value

$313,878

Previous $301,000 25.25%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.63 - $12.66 $96,290 - $159,769	12,620 Added 42.35%	42,416 $377,000
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $32,430 - $44,874	3,771 Added 14.49%	29,796 $301,000
Q4 2023 Feb 09, 2024	SELL	$7.76 - $10.29 $701,837 - $930,658	-90,443 Reduced 77.65%	26,025 $261,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $237,895 - $640,809	26,028 Added 28.78%	116,468 $1.09 Million
Q2 2023 Aug 15, 2023	BUY	$23.2 - $27.29 $471,261 - $554,341	20,313 Added 28.97%	90,440 $2.22 Million
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $1.42 Million - $1.97 Million	63,824 Added 1012.6%	70,127 $1.63 Million
Q4 2022 Feb 13, 2023	SELL	$19.96 - $28.22 $100,997 - $142,793	-5,060 Reduced 44.53%	6,303 $159,000
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $25,290 - $43,073	-1,385 Reduced 10.86%	11,363 $219,000
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $562,306 - $786,875	-29,471 Reduced 69.81%	12,748 $325,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $380,635 - $718,699	-17,963 Reduced 29.85%	42,219 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $11,675 - $20,369	-377 Reduced 0.62%	60,182 $2.52 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $1.49 Million - $2.33 Million	42,761 Added 240.26%	60,559 $2.64 Million
Q2 2021 Aug 16, 2021	SELL	$38.75 - $51.0 $182,551 - $240,261	-4,711 Reduced 20.93%	17,798 $842,000
Q1 2021 May 13, 2021	SELL	$26.34 - $83.07 $2.04 Million - $6.45 Million	-77,602 Reduced 77.52%	22,509 $1.15 Million
Q4 2020 Feb 09, 2021	BUY	$25.51 - $43.38 $1.5 Million - $2.55 Million	58,771 Added 142.16%	100,111 $2.68 Million
Q3 2020 Nov 05, 2020	SELL	$28.28 - $53.6 $743,594 - $1.41 Million	-26,294 Reduced 38.88%	41,340 $1.42 Million
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $1.55 Million - $2.66 Million	55,674 Added 465.5%	67,634 $2.77 Million
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $143,998 - $719,992	11,960 New	11,960 $410,000

Others Institutions Holding VIR

# of Institutions

231

Shares Held

87.6M

Call Options Held

231K

Put Options Held

132K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Vir Biotechnology, Inc. Transaction History